BE827926A - ANTIBIOTIC - Google Patents

ANTIBIOTIC

Info

Publication number
BE827926A
BE827926A BE155402A BE155402A BE827926A BE 827926 A BE827926 A BE 827926A BE 155402 A BE155402 A BE 155402A BE 155402 A BE155402 A BE 155402A BE 827926 A BE827926 A BE 827926A
Authority
BE
Belgium
Prior art keywords
antibiotic
Prior art date
Application number
BE155402A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827926A publication Critical patent/BE827926A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE155402A 1974-04-20 1975-04-14 ANTIBIOTIC BE827926A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17410/74A GB1508977A (en) 1974-04-20 1974-04-20 Beta-lactam antibiotic from streptomyces clavuligerus

Publications (1)

Publication Number Publication Date
BE827926A true BE827926A (en) 1975-10-14

Family

ID=10094711

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155402A BE827926A (en) 1974-04-20 1975-04-14 ANTIBIOTIC

Country Status (6)

Country Link
AT (1) AT352270B (en)
BE (1) BE827926A (en)
CS (1) CS231157B2 (en)
GB (1) GB1508977A (en)
SU (1) SU648117A3 (en)
ZA (1) ZA752492B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2646004A1 (en) * 1975-10-13 1977-04-21 Beecham Group Ltd CLAVULANIC ACID ETHERS, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008525A3 (en) * 1978-08-25 1980-05-28 Beecham Group Plc Pharmaceutical compositions and process for their preparation
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
EP0026044B1 (en) * 1979-08-24 1983-06-08 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) * 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
NZ223316A (en) * 1987-01-29 1989-10-27 Beecham Group Plc Crystalline potassium clavulanate and pharmaceutical compositions
AT400033B (en) 1992-03-10 1995-09-25 Biochemie Gmbh NEW METHOD FOR ISOLATING AND PURIFYING CLAVULANIC ACID AND FOR PRODUCING PHARMACOLOGICALLY COMPATIBLE SALTS THEREOF
AT399155B (en) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih NEW ALKYLENE DIAMMONIUM DICLAVULANATE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
SI9300296B (en) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Process and intermediates for the preparation of clavulanic acid
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (en) * 1992-10-21 1999-06-15 김충환 Process for preparing salts of clavulanic acid
DE4318916A1 (en) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9424950D0 (en) 1994-12-10 1995-02-08 Smithkline Beecham Plc Novel process
EP0729961B1 (en) * 1995-02-25 2001-12-19 Spurcourt Limited Clavulanic acid salt
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ES2101658B1 (en) * 1995-11-23 1998-03-01 Antibioticos Sa NEW PROCEDURE FOR THE PRODUCTION OF CLAVULANIC ACID AND ITS SALTS.
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
AT404728B (en) * 1996-11-27 1999-02-25 Biochemie Gmbh METHOD FOR PRODUCING CLAVULIC ACID AMINE SALTS
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6426342B2 (en) 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
WO2001012184A1 (en) * 1999-08-16 2001-02-22 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
US6489319B2 (en) 1999-08-16 2002-12-03 Revaax Pharmaceuticals, Llc Neurotherapeutic use of carboxypeptidase inhibitors
WO2001087891A1 (en) 2000-05-13 2001-11-22 Smithkline Beecham P.L.C. Process for the purification of a salt of clavulanic acid
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
ES2357595B1 (en) * 2009-10-02 2012-03-15 Instituto Mediterr�?Neo Para El Avance De La Biotecnolog�?A Y La Investigación Sanitaria (Fundación Imabis) COMPOSITION OF � CL CLAVULENT ACID AND USE FOR DIAGNOSIS IN ALLERGOLOGY A A.
TR200909787A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical formulations containing a third generation cephalosporin and clavulanic acid.
TR201000686A1 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Water-soluble cefdinir and clavulanic acid formulations for the treatment of bacterial infections.
TR201000687A1 (en) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Effervescent formulations containing cefixime and clavulanic acid as active ingredient
TR201000688A2 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
CN115433701B (en) * 2022-11-08 2023-03-17 南京农业大学 Proteobacterium, bacterial agent thereof and application of bacterial agent in degrading cephalosporin antibiotics

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4428937A (en) 1975-04-14 1984-01-31 Beecham Group Limited Antibacterial agents
DE2646004A1 (en) * 1975-10-13 1977-04-21 Beecham Group Ltd CLAVULANIC ACID ETHERS, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
WO2013064687A2 (en) 2011-11-04 2013-05-10 Lek Pharmaceuticals D.D. Process for production of clavulanic acid

Also Published As

Publication number Publication date
ATA298575A (en) 1979-02-15
CS231157B2 (en) 1984-10-15
ZA752492B (en) 1976-06-30
SU648117A3 (en) 1979-02-15
AT352270B (en) 1979-09-10
GB1508977A (en) 1978-04-26
CS272175A2 (en) 1984-02-13

Similar Documents

Publication Publication Date Title
BE827926A (en) ANTIBIOTIC
ATA277375A (en) DEODORANTIES
SE7513570L (en) ANTIBIOTIC
ATA962675A (en) SAMASCHINE
SE7514033L (en) NEW ANTIBIOTIC COMPLEX
BE829199A (en) ANTIBIOTIC COMPOSITION
JPS5110228A (en) ATSUSHUKUTENKASHIKIENJINYONENRYOFUNSHASOCHI
JPS5110243A (en) HENDOPITSUCHITATEYOKUGATAFUSHA
DK234275A (en) HARKROLLER
JPS5111011A (en) FUKAJIBORYOARUMINIUMUGOKINPANNO SEIZOHOHO
JPS51105184A (en) IYAKUEKINOYOKIHENOSHOTEIRYOCHUNYU MATAHA KOREYORISHOTEIRYOCHUSHUTSUOOKONAUSOCHI
BR7504801A (en) RODIZIO
FI56437B (en) BRAENNARHUVUD FOER OLJEBRAENNARE
FR2285121A1 (en) HYDROXY-THIO-ALKANES SYMMETRICS
JPS5110140A (en) RYUDENBOSHOKUHO
JPS5110410A (en) KADOYOKUSHIKI ATSUSHUKUKI
DK167475A (en) VEGANKER
JPS511083A (en) MONORISHITSUKUSHUSEKI KAIRONO SEIHO
BE827408A (en) UREIDOCEPHALOSPORINS ANTIBIOTICS
SE7510815L (en) HALF LEADARDON
JPS5131191A (en) SUIREIKAITENTAIINKYOKU X SENKAN
FI53360C (en) SAUTKILT BUTIKSVAOG
DK324875A (en) KOLLERGANG
JPS5110137A (en) ARUMINIUMUKAKOARUKARISHORIHAIEKINO SAISEIHO
DK255175A (en) SKYDERIST

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BEECHAM GROUP LTD

Effective date: 19950414